- 专利标题: NOVEL HUMAN SERUM ALBUMIN MUTANT
-
申请号: US16846003申请日: 2020-04-10
-
公开(公告)号: US20200247872A1公开(公告)日: 2020-08-06
- 发明人: Kenichi TAKAHASHI , Aya YOSHIOKA , Hideto MORIMOTO , Masafumi KINOSHITA
- 申请人: JCR Pharmaceuticals Co., Ltd.
- 优先权: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@b35f80f
- 主分类号: C07K14/765
- IPC分类号: C07K14/765 ; A61K38/00 ; C12N5/16 ; C07K19/00 ; C12N15/09 ; A61P43/00 ; A61P3/00 ; A61P5/06 ; C07K14/61
摘要:
Disclosed are a human serum albumin mutant that can be linked to a physiologically active protein to increase the stability of the protein in the blood, as well as a resulting protein produced by linking with the mutant. The protein produced by linking with the mutant consists of a human serum albumin mutant comprising the amino acid sequence set forth as SEQ ID NO:3 or an amino acid sequence that, in comparison with it, lacks not more than 10 amino acid residues and/or has not more than 10 amino acid residues replaced, with the proviso that the asparagine residue occurring at position 318 and the threonine at position 320 from the N-terminus of the amino acid sequence set forth as SEQ ID NO:3 are preserved and linked by peptide bonds via a single amino acid residue (X) except proline placed between those two amino acid residues, and a physiologically active protein linked to the mutant.
公开/授权文献
- US11046751B2 Human serum albumin mutant 公开/授权日:2021-06-29
信息查询